Williams RO - Search Results

1

cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing T_regs.

Kawalkowska JZ, Ogbechi J, Venables PJ, Williams RO. Kawalkowska JZ, et al. Among authors: williams ro. Sci Adv. 2019 May 1;5(5):eaaw5422. doi: 10.1126/sciadv.aaw5422. eCollection 2019 May. Sci Adv. 2019. PMID: 31049403 Free PMC article.

2

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.

Feldmann M, Brennan FM, Williams RO, Cope AP, Gibbons DL, Katsikis PD, Maini RN. Feldmann M, et al. Among authors: williams ro. Prog Growth Factor Res. 1992;4(3):247-55. doi: 10.1016/0955-2235(92)90022-a. Prog Growth Factor Res. 1992. PMID: 1307491 Review.

3

Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin.

Baboonian C, Venables PJ, Williams DG, Williams RO, Maini RN. Baboonian C, et al. Among authors: williams dg, williams ro. Ann Rheum Dis. 1991 Nov;50(11):772-5. doi: 10.1136/ard.50.11.772. Ann Rheum Dis. 1991. PMID: 1722966 Free PMC article.

4

The immune response to autoantigens and viruses in rheumatic disease.

Venables PJ, Williams DG, Horsfall AC, Williams RO, Stocks MR, Maini RN. Venables PJ, et al. Among authors: williams dg, williams ro. Br J Rheumatol. 1991;30 Suppl 1:70-4. Br J Rheumatol. 1991. PMID: 1991244 Review. No abstract available.

5

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M. Maini RN, et al. Among authors: williams ro. Immunol Rev. 1995 Apr;144:195-223. doi: 10.1111/j.1600-065x.1995.tb00070.x. Immunol Rev. 1995. PMID: 7590814 Review.

6

Targeting TNF alpha for the therapy of rheumatoid arthritis.

Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M. Maini RN, et al. Among authors: williams ro. Clin Exp Rheumatol. 1994 Nov-Dec;12 Suppl 11:S63-6. Clin Exp Rheumatol. 1994. PMID: 7768056 Review.

7

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.

Maini RN, Brennan FM, Williams R, Chu CQ, Cope AP, Gibbons D, Elliott M, Feldmann M. Maini RN, et al. Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S173-5. Clin Exp Rheumatol. 1993. PMID: 8391952 Review.

8

Interleukin-10 inhibition of the progression of established collagen-induced arthritis.

Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M. Walmsley M, et al. Among authors: williams ro. Arthritis Rheum. 1996 Mar;39(3):495-503. doi: 10.1002/art.1780390318. Arthritis Rheum. 1996. PMID: 8607899

9

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.

Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M. Maini RN, et al. Among authors: williams ro. APMIS. 1997 Apr;105(4):257-63. doi: 10.1111/j.1699-0463.1997.tb00567.x. APMIS. 1997. PMID: 9164467 Review.

10

Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.

Ross SE, Williams RO, Mason LJ, Mauri C, Marinova-Mutafchieva L, Malfait AM, Maini RN, Feldmann M. Ross SE, et al. Among authors: williams ro. J Immunol. 1997 Dec 15;159(12):6253-9. J Immunol. 1997. PMID: 9550429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters